All Episodes

April 24, 2025 10 mins
In Episode 137 of the U.S. News Daily Brief, Michelle begins with a welcome and introduction before addressing a report by the American Lung Association on air quality and climate change, highlighting growing concerns. The episode then covers the lawsuit filed by several states against Trump's tariff policy, delving into the economic and legal challenges involved. Michelle examines the pharmaceutical industry's reaction to potential tariffs, discussing implications for the global supply chain. The episode also looks at the Department of Homeland Security's mistaken deportation notices, considering their impact on affected individuals. It concludes with closing remarks and a call to follow the podcast for ongoing updates.
Mark as Played
Transcript

Episode Transcript

Available transcripts are automatically generated. Complete accuracy is not guaranteed.
(00:00):
Welcome back to U.S.

(00:01):
News Daily, your go-to update on the latesthappenings across the United States.
I’m your host, AI Michelle, and this is aMagicPod, produced by PodcastAI.
Want to create your own MagicPod?
Click the link in the show notes.
Alright, let’s dive in.
First up...

(00:23):
A new report has unveiled a concerning trendregarding air quality across the United States.
According to the American Lung Association'sannual State of the Air report, almost half of
U.S.
residents are breathing unhealthy levels of airpollution.
Specifically, the report highlights that about156 million people live in areas that received

(00:45):
a failing grade in terms of smog and sootpollution.
The data, which spans from 2021 to 2023,indicates that 25 million more people are now
exposed to unhealthy air compared to last year.
This means approximately 46% of Americansreside in regions that failed in at least one

of the three pollution measures (01:04):
short-term particle pollution, year-round particle
pollution, and ozone pollution.
Despite the Clean Air Act's success in reducingemissions of the six most common pollutants by
78% since its inception in 1970, recent yearshave seen a resurgence of air pollution.
Laura Kate Bender, an assistant vice presidentat the American Lung Association, attributes

(01:29):
this increase to climate change, whichexacerbates conditions like wildfires and
extreme heat that contribute to higher ozonelevels.
The report identifies Bakersfield, California,as the city with the worst year-round and
short-term particle pollution for the sixthconsecutive year.
On the other hand, Casper, Wyoming, stands outas the cleanest city in the nation regarding

(01:52):
year-round particle pollution.
The report also points out that poor airquality is no longer confined to western states
but is now spreading eastward, driven byclimate change-related factors such as extreme
heat and wildfires.
In 2023, a severe heatwave and smoke fromCanada's wildfires significantly impacted air

(02:14):
quality in central and eastern states.
Recent regulatory rollbacks by theEnvironmental Protection Agency, including
changes to national air quality standards andemission regulations, have raised concerns
about reversing decades of progress.
Kate Bender warns that these changes couldjeopardize the health improvements achieved
over the years by making the air dirtier.

(02:37):
Both ozone and particle pollution havewell-documented health impacts, including
asthma, heart attacks, strokes, and lungcancer.
The report highlights that these pollutants area significant concern for vulnerable
populations, particularly children andeconomically disadvantaged communities of
color.
A dozen states have launched a lawsuit againstthe Trump administration, seeking to halt the

(03:01):
president's controversial tariff policy.
Filed in the United States Court ofInternational Trade in New York, the lawsuit
argues that President Trump's approach toimposing tariffs is both unlawful and chaotic,
with detrimental effects on the Americaneconomy.
The states involved include Oregon, Arizona,Colorado, Connecticut, Delaware, Illinois,

(03:22):
Maine, Minnesota, Nevada, New Mexico, New York,and Vermont.
These states are challenging Trump's use of theInternational Emergency Economic Powers Act,
contending that the president cannotarbitrarily impose tariffs without a legitimate
emergency threat from abroad.
Arizona Attorney General Kris Mayes has calledTrump's tariff policy "insane," labeling it as

(03:45):
economically reckless and illegal.
Similarly, Connecticut Attorney General WilliamTong criticized the tariffs as a significant
tax burden on families and a disaster forbusinesses and jobs in his state.
The lawsuit emphasizes that the power to imposetariffs rests with Congress, not the president.

(04:06):
It argues that Trump's actions have disruptedthe constitutional balance, creating economic
instability by allowing arbitrary tariffimpositions based on perceived emergencies.
In a related development, California GovernorGavin Newsom has also taken legal action
against the Trump administration, highlightingthe potential for billions of dollars in lost

(04:27):
revenue for California due to its status as thelargest importer in the nation.
The White House, through spokesperson KushDesai, has defended the tariffs as part of a
strategy to tackle what it describes as anational emergency impacting American
industries and workers.
The ongoing trade war between the United Statesand China continues to escalate, and its impact

(04:50):
is now extending into the healthcare sector,particularly in pharmaceuticals.
President Donald Trump's administration isconsidering imposing new tariffs on imported
medications and their active ingredients,citing national security concerns.
This potential move could have significantrepercussions for American patients, as the

(05:10):
United States imports seventy-five percent ofits essential medicines, with a heavy reliance
on China.
The proposed tariffs could range from seven anda half percent to a staggering one hundred
percent, adding to the already existing onehundred forty-five percent tariffs on Chinese
goods.
While pharmaceuticals have been exempt fromthese reciprocal tariffs thus far, the future

(05:32):
remains uncertain, with sectoral leviespotentially on the horizon.
In the short term, the complex supply chain inthe pharmaceutical industry provides some
buffer against immediate price hikes.
However, experts warn that the long-termeffects could be severe.
The American healthcare system relies heavilyon international sources for both drugs and

(05:55):
medical supplies, and tariffs could exacerbateexisting supply chain strains, leading to
shortages and increased prices.
India, which supplies about half of all genericdrugs used in the United States, depends on
China for eighty percent of its activepharmaceutical ingredients.
This interconnectedness means that anydisruption in trade with China could ripple

(06:17):
across the global supply chain, impacting drugavailability and affordability.
Pharmaceutical companies like AstraZeneca, EliLilly, and Johnson & Johnson have voiced
concerns over the potential tariffs,emphasizing that medicines should be exempt to
protect patient care and health equity.
These companies have already pledgedsubstantial investments to bolster

(06:40):
manufacturing and research within the UnitedStates, but they caution that absorbing
increased costs is unsustainable in the longrun.
Experts, including Michael Abrams from Numerofand Associates, underscore the socioeconomic
impact of these tariffs, noting that low-incomecommunities will be hit hardest.
Generic drugs, which are significantly cheaperthan their brand-name counterparts, could see

(07:05):
price increases, further straining alreadyburdened healthcare budgets for many Americans.
The American Hospital Association has expressedconcerns that tariffs could reduce the
availability of life-saving medications,particularly for conditions like cancer and
cardiovascular diseases.
The association warns that even temporarydisruptions could pose significant risks to

(07:27):
patient health.
As the debate continues, the White House hasyet to provide a clear response to these
concerns.
Meanwhile, the pharmaceutical industry bracesfor potential disruptions, with companies like
Roche and Novartis planning major investmentsin U.S.
manufacturing to mitigate future risks.

(07:47):
However, these efforts will take time tomaterialize, leaving the immediate future
uncertain for patients reliant on affordablemedications.
In a surprising turn of events, the Departmentof Homeland Security has mistakenly sent
deportation notices to some United Statescitizens, causing confusion and concern among
recipients.

(08:08):
The notices, intended for undocumentedimmigrants, were erroneously delivered to
United States citizens, including immigrationattorney Harriet Steele from Los Angeles.
Harriet Steele received an email late at nightstating, "It is time for you to leave the
United States," despite being a United Statescitizen herself.
The email was a notice of termination ofparole, a legal entry form expanded under the

(08:33):
Biden administration, which seemed to targether mistakenly.
The Department of Homeland Security hasacknowledged the error, stating that some
emails may have been sent to unintendedrecipients due to incorrect email addresses
being used.
Customs and Border Protection has assured thatthey're monitoring the situation and will
address any issues on a case-by-case basis.

(08:56):
This incident has heightened fears withinimmigrant communities and even among legal
practitioners.
Harriet Steele expressed concerns about theTrump administration's approach, which she
describes as operating on a mix of cruelty andincompetence.
She believes this mistake is indicative of thefear the administration is trying to instill.

(09:17):
The American Immigration Lawyers Associationhas issued a practice alert, warning attorneys
about the termination notices.
Many have received similar notices, even thosenot involved in the parole process, adding to
the confusion and anxiety.
This blunder comes amidst the Trumpadministration's broader efforts to revoke

(09:37):
legal statuses and work authorizations ofmigrants who entered the United States through
the Biden-era border appointment app, affectingpotentially hundreds of thousands.
As the situation unfolds, immigrant rightsactivists are reporting that some individuals,
fearing deportation, are choosing toself-deport.

(09:58):
The administration's hardline stance continuesto create ripples of uncertainty across
communities.
Alright, that's a wrap for this episode.
If you enjoyed this brief, and would like tostay updated on latest episodes, don’t forget
to click ‘Follow’ in your podcast app.
Thanks again for listening, and hope to catchyou next time.
Advertise With Us

Popular Podcasts

Stuff You Should Know
My Favorite Murder with Karen Kilgariff and Georgia Hardstark

My Favorite Murder with Karen Kilgariff and Georgia Hardstark

My Favorite Murder is a true crime comedy podcast hosted by Karen Kilgariff and Georgia Hardstark. Each week, Karen and Georgia share compelling true crimes and hometown stories from friends and listeners. Since MFM launched in January of 2016, Karen and Georgia have shared their lifelong interest in true crime and have covered stories of infamous serial killers like the Night Stalker, mysterious cold cases, captivating cults, incredible survivor stories and important events from history like the Tulsa race massacre of 1921. My Favorite Murder is part of the Exactly Right podcast network that provides a platform for bold, creative voices to bring to life provocative, entertaining and relatable stories for audiences everywhere. The Exactly Right roster of podcasts covers a variety of topics including historic true crime, comedic interviews and news, science, pop culture and more. Podcasts on the network include Buried Bones with Kate Winkler Dawson and Paul Holes, That's Messed Up: An SVU Podcast, This Podcast Will Kill You, Bananas and more.

The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.